Table 1. Anthropometric and laboratory data and comparison parameters.
n (%) | Pretreatment | SVR | p-value | ||
---|---|---|---|---|---|
Age (mean±SD) | 57.03 (±11.11) | ||||
≤54 years | 98 (35.9) | ||||
55–64 years | 113 (41.4) | ||||
≥65 years | 62 (22.7) | ||||
Color | |||||
White | 193 (70.7) | ||||
Nonwhite | 80 (29.3) | ||||
Genre | |||||
Male | 144 (52.7) | ||||
Female | 129 (47.3) | ||||
Weight (mean±SD) | 73.54 (±14.69) | 0.127 | |||
WC Abdominal (mean±SD) | 73.21 (±14.72) | 94.04 (±11.99) | 0.206 | ||
Adequate | 73 (29.3) | 94.38 (±11.87) | |||
Inadequate | 200 (70.7) | ||||
BMI (mean±SD) | 25.59 (±4.76) | 27.73 (±4.84) | 0.093 | ||
≤24.9 (81) | 81 (29.7) | ||||
25–29.9 (116) | 117 (42.9) | ||||
≥30 (74) | 75 (27.5) | ||||
Glycemic profile (mean±SD) | 101.84 (±27.29) | 107.79 (±31.70) | 0.976 | ||
With normal blood glucose | 98 (35.9) | ||||
With prediabetes | 125 (45.8) | ||||
With diabetes | 50 (18.3) | ||||
Glycemic/genotypes (mean±SD) | |||||
Genotype 1 (146) | 105.02 (±21.01) | 104.27 (±22.23) | 0.541 | ||
enotype 2 (38) | 115.47 (±42.31) | 116.00 (±37.23) | 0.889 | ||
Genotype 3 (87) | 109.28 (±28.10) | 110.25 (±40.57) | 0.775 | ||
Profile triglycerides (mean±SD) | |||||
Genotype 1 (146) | 101.87 (±66.30) | 105.30 (±66.47) | 0.416 | ||
Genotype 2 (38) | 104.95 (±49.45) | 109.51 (±54.57) | 0.563 | ||
Genotype 3 (87) | 79.85 (±31.56) | 100.94 (±76.15) | 0.031 | ||
Laboratories (mean±SD) | |||||
Total cholesterol | 166.37 (±36.91) | 185.52 (±38.41) | <0.001 | ||
LDL | 97.30 (±33.86) | 111.80 (±36.66) | <0.001 | ||
HDL | 49.59 (±14.23) | 50.26 (±13.66) | 0.652 | ||
Triglycerides | 95.44 (±55.67) | 104.47 (±67.50) | 0.006 |
BMI: body mass index; WC: waist circumference; HbA1c: glycated hemoglobin; HDL: high-density lipoprotein; LDL: low-density lipoprotein; SD: standard deviation; SVR: sustained viral response.